• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阐明严重急性呼吸综合征冠状病毒 2 的免疫病理学。

Illuminating the immunopathology of SARS-CoV-2.

机构信息

BD Biosciences, San Jose, California, USA.

NYU Langone Medical Center, New York, New York, USA.

出版信息

Cytometry B Clin Cytom. 2021 Jan;100(1):33-41. doi: 10.1002/cyto.b.21988. Epub 2021 Jan 4.

DOI:10.1002/cyto.b.21988
PMID:33394568
Abstract

Over a remarkably short period of time, a great deal of knowledge about severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) infection has been acquired, through the focused and cooperative effort of the international scientific community. Much has become known about how the immune response is coordinated to fight infection, and how it becomes dysregulated in severe disease. In this review, we take an in-depth look at the many immune features associated with the host response to SARS-CoV2, as well as those that appear to mark severe disease.

摘要

在相当短的时间内,通过国际科学界的集中协作,人们对严重急性呼吸综合征冠状病毒 2(SARS-CoV2)感染有了大量的了解。人们已经了解了免疫反应是如何协调来对抗感染的,以及在严重疾病中它是如何失调的。在这篇综述中,我们深入研究了与宿主对 SARS-CoV2 反应相关的许多免疫特征,以及那些似乎标志着严重疾病的免疫特征。

相似文献

1
Illuminating the immunopathology of SARS-CoV-2.阐明严重急性呼吸综合征冠状病毒 2 的免疫病理学。
Cytometry B Clin Cytom. 2021 Jan;100(1):33-41. doi: 10.1002/cyto.b.21988. Epub 2021 Jan 4.
2
Monocytes and Macrophages, Targets of Severe Acute Respiratory Syndrome Coronavirus 2: The Clue for Coronavirus Disease 2019 Immunoparalysis.单核细胞和巨噬细胞:严重急性呼吸综合征冠状病毒 2 的作用靶点:2019 冠状病毒病免疫麻痹的线索。
J Infect Dis. 2021 Aug 2;224(3):395-406. doi: 10.1093/infdis/jiab044.
3
Long-term coexistence of SARS-CoV-2 with antibody response in COVID-19 patients.COVID-19 患者体内的 SARS-CoV-2 与抗体反应的长期共存。
J Med Virol. 2020 Sep;92(9):1684-1689. doi: 10.1002/jmv.25946. Epub 2020 May 5.
4
Mechanisms underlying host defense and disease pathology in response to severe acute respiratory syndrome (SARS)-CoV2 infection: insights from inborn errors of immunity.先天免疫缺陷相关疾病对严重急性呼吸综合征冠状病毒 2 感染宿主防御和疾病发病机制的启示
Curr Opin Allergy Clin Immunol. 2021 Dec 1;21(6):515-524. doi: 10.1097/ACI.0000000000000786.
5
Innate immune evasion by SARS-CoV-2: Comparison with SARS-CoV.SARS-CoV-2 的先天免疫逃避:与 SARS-CoV 的比较。
Rev Med Virol. 2020 Nov;30(6):1-9. doi: 10.1002/rmv.2135. Epub 2020 Jul 30.
6
SARS-CoV-2 multifaceted interaction with the human host. Part II: Innate immunity response, immunopathology, and epigenetics.SARS-CoV-2 与人类宿主的多方面相互作用。第二部分:先天免疫反应、免疫病理学和表观遗传学。
IUBMB Life. 2020 Nov;72(11):2331-2354. doi: 10.1002/iub.2379. Epub 2020 Sep 16.
7
SARS-CoV-2-specific virulence factors in COVID-19.COVID-19 中的 SARS-CoV-2 特异性毒力因子。
J Med Virol. 2021 Mar;93(3):1343-1350. doi: 10.1002/jmv.26615. Epub 2020 Nov 1.
8
Divergent SARS-CoV-2-specific T- and B-cell responses in severe but not mild COVID-19 patients.在重症 COVID-19 患者中而非轻症 COVID-19 患者中存在不同的 SARS-CoV-2 特异性 T 细胞和 B 细胞反应。
Eur J Immunol. 2020 Dec;50(12):1998-2012. doi: 10.1002/eji.202048908. Epub 2020 Nov 16.
9
Diagnosis of SARS-CoV-2 infection in the setting of the cytokine release syndrome.在细胞因子释放综合征背景下 SARS-CoV-2 感染的诊断。
Expert Rev Mol Diagn. 2020 Nov;20(11):1087-1097. doi: 10.1080/14737159.2020.1830760. Epub 2020 Oct 12.
10
Evidence and implications of pre-existing humoral cross-reactive immunity to SARS-CoV-2.针对 SARS-CoV-2 的预先存在的体液交叉反应性免疫的证据和影响。
Immun Inflamm Dis. 2021 Mar;9(1):128-133. doi: 10.1002/iid3.367. Epub 2020 Dec 15.

引用本文的文献

1
SARS-CoV-2 ORF8 as a Modulator of Cytokine Induction: Evidence and Search for Molecular Mechanisms.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)开放阅读框8作为细胞因子诱导的调节因子:证据及分子机制探索
Viruses. 2024 Jan 22;16(1):161. doi: 10.3390/v16010161.
2
Peripheral innate and adaptive immune cells during COVID-19: Functional neutrophils, pro-inflammatory monocytes, and half-dead lymphocytes.COVID-19 期间的外周先天和适应性免疫细胞:功能失调的中性粒细胞、促炎单核细胞和濒死的淋巴细胞。
Cytometry B Clin Cytom. 2022 Mar;102(2):153-167. doi: 10.1002/cyto.b.22042. Epub 2021 Nov 30.
3
Propofol Ameliorates Exaggerated Human Neutrophil Activation in a LPS Sepsis Model.
丙泊酚改善脂多糖诱导的脓毒症模型中人类中性粒细胞的过度激活。
J Inflamm Res. 2021 Aug 11;14:3849-3862. doi: 10.2147/JIR.S314192. eCollection 2021.
4
Obesity and severe coronavirus disease 2019: molecular mechanisms, paths forward, and therapeutic opportunities.肥胖与严重的 2019 冠状病毒病:分子机制、前进方向和治疗机会。
Theranostics. 2021 Jul 13;11(17):8234-8253. doi: 10.7150/thno.59293. eCollection 2021.
5
Clinical laboratory evaluation of COVID-19.新型冠状病毒肺炎的临床实验室评估
Clin Chim Acta. 2021 Aug;519:172-182. doi: 10.1016/j.cca.2021.04.022. Epub 2021 Apr 30.
6
Multiple Sclerosis and SARS-CoV-2 Vaccination: Considerations for Immune-Depleting Therapies.多发性硬化症与SARS-CoV-2疫苗接种:免疫耗竭疗法的考量
Vaccines (Basel). 2021 Jan 28;9(2):99. doi: 10.3390/vaccines9020099.